Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 821-830 of 9364

Page
per page
  1. Motolimod (VTX-2337)
    B5996 Motolimod (VTX-2337)
    Target: Toll-like receptors (TLRs)
    Summary: TLR8 agonist
      insoluble in H2O; ≥15.7 mg/mL
  2. GSK2801
    B5998 GSK2801
    Summary: inhibitor of BAZ2A and BAZ2B bromodomains
      insoluble in H2O; ≥18.55 mg/mL
  3. FLLL32
    B5999 FLLL32
    Summary: STAT3 inhibitor
  4. K-Ras(G12C) inhibitor 9
    B6002 K-Ras(G12C) inhibitor 9
    Summary: allosteric inhibitor of oncogenic K-Ras(G12C)
      Soluble in DMSO
  5. SB273005
    B6003 SB273005
    Summary: αvβ3 antagonist
      Soluble in DMSO
  6. PX-478 2HCl
    B6004 PX-478 2HCl
     6 Citation
    Target: Hypoxia Inducible Factors (HIFs)
    Summary: HIF-1α inhibitor
      ≥19.7 mg/mL
  7. Peficitinb (ASP015K, JNJ-54781532)
    B6005 Peficitinb (ASP015K, JNJ-54781532)
    Summary: JAK inhibitor
      ≥23.2 mg/mL
  8. NPS-1034
    B6006 NPS-1034
    Summary: MET inhibitor
      Soluble in DMSO
  9. AZD6738
    B6007 AZD6738
     1 Citation
    Target: ATM/ATR
    Summary: ATR inhibitor
      insoluble in H2O; ≥82 mg/mL
  10. BPTES
    B6008 BPTES
    Target: Glutaminases
    Summary: GLS inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18 mg/mL

Items 821-830 of 9364

Page
per page